Navigation Links
Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351
Date:11/18/2008

merican Cancer Society's Cancer Facts and Figures estimates 13,290 new cases of AML and 8,820 deaths.

About Celator

Celator Pharmaceuticals, Inc., with locations in Princeton, NJ, and Vancouver, BC, is a privately held pharmaceutical company developing new and more effective therapies to treat cancer. CombiPlex(R), the company's drug ratio technology platform, represents a revolutionary new approach to the development of combination therapies based on identifying a fixed, synergistic ratio of the drugs pre-clinically, incorporating that ratio in a drug delivery vehicle and maintaining the ratio in patients. The company pipeline includes: CPX-1 (a liposomal formulation of irinotecan:floxuridine), currently in Phase 2 in patients with colorectal cancer; CPX-351 (a liposomal formulation of cytarabine:daunorubicin), currently in Phase 2 in patients with acute myeloid leukemia; CPX-571 (a liposomal formulation of irinotecan:cisplatin), a preclinical stage compound; and multiple research programs. Based on the applications of CombiPlex, Celator is positioned to advance a broad pipeline of combination therapies involving both previously approved and novel drug agents. For more information, please visit the company's website at www.celatorpharma.com.


'/>"/>
SOURCE Celator Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Celator(R) Pharmaceuticals Announces Positive Phase 2 Results for CPX-1 in Treatment of Colorectal Cancer
2. Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations
3. Celator(R) Pharmaceuticals Reports CPX-351 Shows Anti-Cancer Activity in Leukemia Patients
4. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
5. Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire dAngers for Phase II Clinical Trial in Huntingtons Disease
6. VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease
7. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
8. Poniard Pharmaceuticals Announces Final Top-Line Results from Phase 1 Trial Demonstrating Positive Bioavailability with Oral Picoplatin
9. VIA Pharmaceuticals Announces Conference Call and Webcast to Discuss VIA-2291 Phase 2 Data Presentations at AHA
10. Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium
11. Raptor Pharmaceuticals Provides Update on Targeting Platforms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... , May 22, 2013  For the 3% of the ... is often embarrassing, uncomfortable, anxiety-inducing and disabling.  While more ... treated for their symptoms, hyperhidrosis is a serious medical ... available called Precision TX™. Dr. ... & Laser Center in New York ...
(Date:5/22/2013)... May 22, 2013  Modern Medical announced today ... Launched in November 2012 in a test phase, ... to stop the rising opioid abuse in the ... program designed to protect employees, physicians and employers ... necessary balance to provide pain relief for the ...
(Date:5/22/2013)... 2013 STEPh, Inc., a full service medical ... their web site ( http://www.stephreports.com ) dedicated ... About STEPh Reports STEPh Reports are comprehensive ... Each STEPh Report assesses the competitive landscape by individual ... company, and specific key issues.  STEPh Reports are written ...
Breaking Medicine Technology:Is There Finally A Way To Stop Severe Excessive Sweating? 2Modern Medical Introduces Opioid Abuse Solution to the Workers' Compensation Industry 2Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site 2
... Oct. 20 Young Innovations, Inc. (Nasdaq: YDNT ) ... quarter and the nine-months ended September 30, 2010. ... increase of 6.5% over the $24.8 million reported for the third ... 7.6% to $6.1 million from $5.7 million in the prior year ...
... INDIANAPOLIS, Oct. 20 MacroGenics, Inc. and Eli Lilly ... that the Protege Data Monitoring Committee (DMC), composed of ... has completed a planned analysis of one-year safety and ... of teplizumab, an investigational biologic under development for the ...
Cached Medicine Technology:Young Innovations, Inc. Announces Record Sales and EPS for the Quarter and Nine-Months Ended September 30, 2010 and Declares Quarterly Dividend 2Young Innovations, Inc. Announces Record Sales and EPS for the Quarter and Nine-Months Ended September 30, 2010 and Declares Quarterly Dividend 3Young Innovations, Inc. Announces Record Sales and EPS for the Quarter and Nine-Months Ended September 30, 2010 and Declares Quarterly Dividend 4Young Innovations, Inc. Announces Record Sales and EPS for the Quarter and Nine-Months Ended September 30, 2010 and Declares Quarterly Dividend 5MacroGenics and Lilly Announce Pivotal Clinical Trial of Teplizumab Did Not Meet Primary Efficacy Endpoint 2MacroGenics and Lilly Announce Pivotal Clinical Trial of Teplizumab Did Not Meet Primary Efficacy Endpoint 3
(Date:5/22/2013)... of internal medicine residents at Massachusetts General Hospital (MGH) ... found that more than half rated the training they ... as fair or poor. Significant numbers felt unprepared to ... of practicing physicians. In response to the findings, recently ... the MGH has increased residents, training in addiction medicine. ...
(Date:5/22/2013)... father,s depression have on his young son or daughter? When ... marriage, their children benefit, said a University of Illinois study. ... need to be able to attend to the child,s emotional ... and notice whether he is getting frustrated or needs help. ... a U of I professor of human development. , But ...
(Date:5/22/2013)... IL A new study suggests that disturbed ... of depression and greater uncertainly about future success. ... and teachers appears to have a protective effect. ... significantly associated with depressed mood and greater uncertainty ... from parents and from teachers were associated with ...
(Date:5/22/2013)... plants" that make energy to keep cells alive is ... the drug-resistant forms of cancer source of a ... of a new study published in the journal ... colleagues explain that doxorubicin and other common forms of ... of cancer cells. Cancer cells divide and multiply faster ...
(Date:5/22/2013)... The newest member of TeethWhiteningforFree.com is Dr. ... Alabama graduate, Dr. Sanderson provides professional dental care to ... he extends complimentary teeth whitening to his patients who ... up. Only a dental professional can decide if the ... , Teeth whitening is an easy way ...
Breaking Medicine News(10 mins):Health News:Survey points out deficiencies in addictions training for medical residents 2Health News:Survey points out deficiencies in addictions training for medical residents 3Health News:Survey points out deficiencies in addictions training for medical residents 4Health News:Good marriage can buffer effects of dad's depression on young children 2Health News:Parent and teacher support protects teens from sleep problems and depression 2Health News:Dr. James Sanderson, Jr. Of SanDentistry in Hoover, Alabama Joins the TeethWhiteningforFree.com Family 2
... A Closer Look at The Value of,MRIs ... of,America,s (MSAA) website, http://www.msassociation.org . This three ... offering a first-hand,account on the experience of undergoing ... well as the importance of MRIs to monitor ...
... N.C., June 5 Benchmarking is not a luxury;,it ... climates. This research,excerpt presents a survey analysis of 30 ... how companies are using benchmarking in a,difficult economy., ... companies are,choosing to benchmark, the goals of benchmarking studies, ...
... The Massachusetts School of,Professional Psychology, WEST ROXBURY, ... state about the ,invisible wounds of war, - ... depression and post traumatic,stress disorder (PTSD) - which ... and suicide. We need to begin focusing on ...
... information, giveaways, entertainment and ... ... with professional fitness and figure competitors Allison,Frahn and Tina Durkin, will represent ... Cobb Galleria Centre in Atlanta., Chad, part of the World Natural ...
... Cline Davis & Mann (CDM), a ... of its,newest division, Platform Advisors(TM). Platform Advisors, ... and scientific consulting,services for pharmaceutical, biotechnology, and ... firms, Platform Advisors combines the,expertise of seasoned ...
... barriers cited, particularly in construction jobs, CDC reports ... workers face a greater risk of dying from ... in the construction industry, U.S. health officials said ... workers died from work-related injuries. This represents approximately ...
Cached Medicine News:Health News:Photos: The Multiple Sclerosis Association of America Produces a Web Video on the Importance of MRIs 2Health News:Demonstrating the Value of Benchmarking in an Uncertain Economy 2Health News:Growing Public Health Crisis of Domestic Violence and Suicides by Returning Veterans 2Health News:Rite Aid Health and Beauty Expo to Showcase GNC Athletes 2Health News:Cline Davis & Mann Launches Platform Advisors(TM), a New Division to Provide Integrated Strategic and Scientific Consulting Services for the Pharmaceutical, Biotechnology, and Medical Device Industry 2Health News:Hispanic Workers Dying at Higher Rates Than Others 2Health News:Hispanic Workers Dying at Higher Rates Than Others 3
... SpecTRACK Software is an Informatics software product ... of specimens for the laboratory. With SpecTRACK ... location of any specimen from all laboratories ... in the refrigerator or cold room. Automate ...
PediaVision LLC is a life sciences company dedicated to solving the critical problem of undiagnosed vision problems affecting children worldwide....
... only contact lenses designed to address two ... eyes: presbyopia and eye dryness. , Only ... design, Balanced Progressive Technology, with a unique ... Technology. The result? Lenses that give you ...
... encountered complication in cataract surgery. Should a ... many surgeons advocate the use of flexible iris ... for maximum visibility during the procedure. These ... and can be easily inserted through four evenly ...
Medicine Products: